Krensavage Asset Management, LLC Supernus Pharmaceuticals, Inc. Transaction History
Krensavage Asset Management, LLC
- $181 Million
- Q1 2025
A detailed history of Krensavage Asset Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 431,986 shares of SUPN stock, worth $13.7 Million. This represents 7.82% of its overall portfolio holdings.
Number of Shares
431,986Holding current value
$13.7 Million% of portfolio
7.82%Shares
1 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$329 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$195 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$165 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$92 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$85.6 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.7B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...